Last reviewed · How we verify
aerosol inhaled Amikacin Sulfate Injection
aerosol inhaled Amikacin Sulfate Injection is a Aminoglycoside antibiotic Small molecule drug developed by Shanghai Zhongshan Hospital. It is currently in Phase 3 development for Treatment of complicated urinary tract infections, including pyelonephritis. Also known as: Aerosol Inhaled investigation drug.
Amikacin Sulfate Injection works by inhibiting bacterial protein synthesis.
Amikacin Sulfate Injection works by inhibiting bacterial protein synthesis. Used for Treatment of complicated urinary tract infections, including pyelonephritis.
At a glance
| Generic name | aerosol inhaled Amikacin Sulfate Injection |
|---|---|
| Also known as | Aerosol Inhaled investigation drug |
| Sponsor | Shanghai Zhongshan Hospital |
| Drug class | Aminoglycoside antibiotic |
| Target | 30S ribosomal subunit |
| Modality | Small molecule |
| Therapeutic area | Infectious disease |
| Phase | Phase 3 |
Mechanism of action
Amikacin Sulfate Injection is an aminoglycoside antibiotic that binds to the 30S ribosomal subunit of bacteria, thereby inhibiting protein synthesis and ultimately leading to bacterial cell death.
Approved indications
- Treatment of complicated urinary tract infections, including pyelonephritis
Common side effects
- Ototoxicity
- Nephrotoxicity
- Hypokalemia
Key clinical trials
- Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract (EARLY_PHASE1)
- Inhaled Amikacin in Preventing AECOPD (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- aerosol inhaled Amikacin Sulfate Injection CI brief — competitive landscape report
- aerosol inhaled Amikacin Sulfate Injection updates RSS · CI watch RSS
- Shanghai Zhongshan Hospital portfolio CI
Frequently asked questions about aerosol inhaled Amikacin Sulfate Injection
What is aerosol inhaled Amikacin Sulfate Injection?
How does aerosol inhaled Amikacin Sulfate Injection work?
What is aerosol inhaled Amikacin Sulfate Injection used for?
Who makes aerosol inhaled Amikacin Sulfate Injection?
Is aerosol inhaled Amikacin Sulfate Injection also known as anything else?
What drug class is aerosol inhaled Amikacin Sulfate Injection in?
What development phase is aerosol inhaled Amikacin Sulfate Injection in?
What are the side effects of aerosol inhaled Amikacin Sulfate Injection?
What does aerosol inhaled Amikacin Sulfate Injection target?
Related
- Drug class: All Aminoglycoside antibiotic drugs
- Target: All drugs targeting 30S ribosomal subunit
- Manufacturer: Shanghai Zhongshan Hospital — full pipeline
- Therapeutic area: All drugs in Infectious disease
- Indication: Drugs for Treatment of complicated urinary tract infections, including pyelonephritis
- Also known as: Aerosol Inhaled investigation drug
- Compare: aerosol inhaled Amikacin Sulfate Injection vs similar drugs
- Pricing: aerosol inhaled Amikacin Sulfate Injection cost, discount & access